PKM and hepatocellular carcinoma: Although there are studies that show that circRNA circMAT2B can activate miR-338-3p/PKM2 axis to enhance the glycolysis process under hypoxia and promote liver cell carcinoma growth,[48] whether it can also regulate PKM2’s non-metabolic enzyme function remains to be further studied.